Mr. William Williams reports

BRIACELL ANNOUNCES INVESTOR AND MEDIA OUTREACH PROGRAM

Briacell Therapeutics Corp. has recently expanded its investor and media outreach platform to enhance communication with investors and increase investor awareness of and interest in the company, its product candidates and its clinical programs. The comprehensive program is expected to enhance Briacell's dialogue with institutional and retail investors, industry analysts, and the investing public. The following investor relations and public relations groups are currently engaged by the company. It is important to disclose that Briacell is unrelated and unaffiliated with each of the following entities, but the following firms and their clients may have an interest, directly or indirectly, in the securities of Briacell.

CorProminence LLC, doing business as Core IR: Based in Garden City, N.Y., Core IR is a leading investor relations firm that provides investor relations services pursuant to a marketing and consulting agreement dated March 15, 2021, and amended on April 9, 2021. Services will include the initiation of strategic market and investor awareness programs by providing comprehensive corporate and shareholder communications development services that will promote the company's brand. All such services and goals are subject to the prior approval of the company. The agreement has a six-month term and thereafter automatically renews for consecutive six-month terms, unless Briacell or Core IR provide written notice of its intention not to renew the agreement five days prior to the end of the initial term or any renewal term. Core IR will be compensated out of working capital in monthly instalments of $13,500 (U.S.). In addition to the monthly retainer, Briacell has granted Core IR an option to purchase up to 60,000 common shares of Briacell under Briacell's stock option plan dated Nov. 24, 2014. The options are exercisable at $4.24 (U.S.) per common share of Briacell. The right to exercise the options vests in four quarterly instalments of 15,000 shares while the contract is in effect, with the first instalment to vest on July 12, 2021. Briacell has no interest in Core IR or its securities. Core IR has no interest in Briacell or its securities, except as set out in this news release. Core IR is not a non-arm's-length party of Briacell, as that term is defined in TSX Venture Exchange policies. The engagement of Core IR remains subject to the approval of the TSX-V.

Dig Media Inc., doing business as Investing News Network: INN is a private company headquartered in Vancouver, Canada, dedicated to providing independent news and education to investors since 2007. Briacell entered into a campaign allocation agreement with INN on March 29, 2021, for a term of 12 months. Pursuant to the INN agreement, INN will provide advertising to increase awareness of the company. INN does not provide investor relations or market-making services. The INN agreement is a non-cancellable binding contract. INN will be compensated out of working capital semi-annually in the amount of $68,000 (U.S.). INN currently holds 1,163 shares of Briacell. INN is not a non-arm's-length party of Briacell, as that term is defined in TSX Venture Exchange policies. The engagement of INN remains subject to the approval of the TSX-V.

SmallCapVoice.com Inc.: Based in Cedar Park, Tex., SmallCapVoice.com is a leading on-line marketing and investor relations firm that specializes in providing investor communication services to small-capitalization companies using on-line tools like search engine optimization (SEO), social media, e-mail campaigns and audio interviews. It is known for its ability to help emerging growth companies build a following among retail and institutional investors in the United States and Canada. On March 24, 2020, Briacell entered into a financial public relations agreement with SmallCapVoice for a term of one month. Services provided to the company under the SmallCapVoice agreement include social media, e-mail campaigns and audio interviews. SmallCapVoice shall be compensated out of working capital at the end of each month in the amount of $3,250 (U.S.). Either party to the SmallCapVoice agreement may terminate the SmallCapVoice agreement upon one-month notice to the other party. The engagement of SmallCapVoice remains subject to the approval of the TSX-V.

Pursuant to an option issuance announced previously in March, 2021, the options will have an amended effective date of April 13, 2021. All other terms and quantities remain the same.

About Briacell Therapeutics Corp.

Briacell is an immuno-oncology-focused biotechnology company, developing targeted and effective approaches for the management of cancer.

We seek Safe Harbor.